Business
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\n Los Angeles, CA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a US-based commercial medical device company -- today announced its inclusion on the Federal Supply Schedule (FSS) for SofPulse® Pulsed Electro Magnetic Field (PEMF) medical devices for distribution throughout the Federal healthcare supply channels. The listing was spearheaded by Endonovo’s partner, Academy Medical Inc, a Service-Disabled Veteran-Owned Small Business (SDVOSB) government reseller. Academy Medical’s efforts to secure SofPulse® on the exclusive FSS is the first of many strategic moves for Endonovo to streamline the distribution of its medical products throughout government healthcare systems. Expanding Distribution for FDA-Cleared Surgical Solutions SofPulse® is an FDA-Cleared medical device which is recognized for its exceptional efficacy for postoperative reduction of pain and edema (inflammation). Clinical studies and patient use have shown that PEMF has the capacity to alleviate pain, promote recovery and enhance overall patient well-being. As SofPulse® is non-invasive, opioid-free and with its potential to speed up recovery, it sets it apart in the medical technology landscape. The inclusion of SofPulse® on the FSS signifies not only a stamp of approval from Federal authorities, but further affirms the Company’s objective of having SofPulse® widely distributed within the government healthcare sectors. \"This endorsement reaffirms our commitment to delivering cutting-edge solutions that cater to diverse healthcare needs” according to Ira Weisberg, President of Endonovo’s Medical Division. Listing on the FSS is a testament to the efficacy and potential of SofPulse® within the U.S. and global medical community,” he pointed out. SofPulse® Positioned for Accelerated Revenue Growth SofPulse® listing on the FSS places its proven PEMF recovery technology at the forefront of distribution, paving the way for exponential growth within the Veterans Administration (VA) and Department of Defense as well as other governmental healthcare sectors. The VA utilizes the FSS to make available a wide range of authorized products and services on an ongoing basis. “Securing a coveted place on the prestigious FSS for SofPulse® PEMF products i...